8-K Inhibikase Therapeutics, Inc. 2026-09-08: filing_form_type
| Value | {"value": "8-K"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K Inhibikase Therapeutics, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1750149/000119312526385293/0001193125-26-385293-in
Retrieved: 2026-09-08T22:50:45.952573+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/365b0cd2-dc25-40cd-89ac-91999f055793
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1750149/000119312526385293/0001193125-26-385293-in
Retrieved: 2026-09-08T22:50:45.952573+02:00
Raw response sha256:
d0fbeebd04e5935d5219431393cd6cdf…Cite as: FACTANKER, https://factanker.com/fact/365b0cd2-dc25-40cd-89ac-91999f055793
History
- no predecessors — first report